BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31382146)

  • 1. The association of ToRCH infection and congenital malformations: A prospective study in China.
    Wang Y; Li S; Ma N; Zhang Q; Wang H; Cui J; Wang S
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():336-340. PubMed ID: 31382146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study.
    Zhang L; Wang X; Liu M; Feng G; Zeng Y; Wang R; Xie Z
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010861. PubMed ID: 36240247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TORCH infection in women with bad obstetric history--a pilot study in Kumaon region.
    Thapliyal N; Shukla PK; Kumar B; Upadhyay S; Jain G
    Indian J Pathol Microbiol; 2005 Oct; 48(4):551-3. PubMed ID: 16366124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of torch infections and its associated poor outcome in high-risk pregnant women of Central India: Time to think for prevention strategies.
    Manjunathachar HV; Singh KN; Chouksey V; Kumar R; Sharma RK; Barde PV
    Indian J Med Microbiol; 2020; 38(3 & 4):379-384. PubMed ID: 33154250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
    Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Previous TORCH Infections and Pregnancy and Neonatal Outcomes in IVF/ICSI-ET: A Retrospective Cohort Study.
    Liu Y; Wu Y; Wang F; Wang S; Zhao W; Chen L; Tu S; Qian Y; Liao Y; Huang Y; Zhang R; Xu G; Zhang D
    Front Endocrinol (Lausanne); 2020; 11():466. PubMed ID: 32849269
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reproductive outcome induced by Parvovirus B19 and TORCH infections in women with high-risk pregnancy.
    Kishore J; Misra R; Paisal A; Pradeep Y
    J Infect Dev Ctries; 2011 Dec; 5(12):868-73. PubMed ID: 22169786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
    Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
    Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TORCH infections in mothers as a cause of neonatal morbidity].
    Mladina N; Mehikić G; Pasić A
    Med Arh; 2000; 54(5-6):273-6. PubMed ID: 11219902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction.
    Yamamoto R; Ishii K; Shimada M; Hayashi S; Hidaka N; Nakayama M; Mitsuda N
    J Obstet Gynaecol Res; 2013 Mar; 39(3):653-7. PubMed ID: 23107457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women.
    De Carolis S; Tabacco S; Rizzo F; Perrone G; Garufi C; Botta A; Salvi S; Benedetti Panici P; Lanzone A
    Lupus; 2018 Apr; 27(5):841-846. PubMed ID: 29157179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between TORCH infection and lupus anticoagulant antibody in pregnant women with recurrent abortion.
    Fatah HR
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):162-166. PubMed ID: 38158672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between TORCH infections and abnormal pregnant outcomes].
    Zhang QQ; Cheng JZ; Wang FH
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):209-10. PubMed ID: 23894850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ToRCH "co-infections" are associated with increased risk of abortion in pregnant women.
    Rasti S; Ghasemi FS; Abdoli A; Piroozmand A; Mousavi SG; Fakhrie-Kashan Z
    Congenit Anom (Kyoto); 2016 Mar; 56(2):73-8. PubMed ID: 26499091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China.
    Qi Y; Zhu S; Li C; Wu H; Yue H; Zhang Y; Zhu B; Ma J; Feng Z; Kong H; Cai X; Ruan Q
    Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():114-118. PubMed ID: 32957008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for TORCH infections in pregnant women: a report from Delhi.
    Kaur R; Gupta N; Nair D; Kakkar M; Mathur MD
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):284-6. PubMed ID: 10774696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the relationship between the history of abnormal pregnancy and TORCH infection in pregnant woman].
    Cao Y; Qiu L; Zhang Q
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):517-20. PubMed ID: 11360633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of holoprosencephaly and cebocephaly associated to torch infection.
    Kilic N; Yazici Z
    Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1275-8. PubMed ID: 16061113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal.
    Kumari N; Morris N; Dutta R
    J Health Popul Nutr; 2011 Feb; 29(1):77-80. PubMed ID: 21528793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TORCH screening in polyhydramnios: an observational study.
    Fayyaz H; Rafi J
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1069-72. PubMed ID: 21923307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.